Pre-Conference Educational

Paediatric Course I

Cost: €50 - (Places must be pre-booked)

Chairs: F Schaefer, Heidelberg, Germany; B Warady, Kansas City, USA

13.00–13.30 PD Prescription: Fill Volume, Dwell Time
M Fischbach, Strasbourg, France
How to prescribe a fill volume from babies to adolescents; which impact on tolerance and dialysis efficacy; the importance of the dwell time on ultrafiltration and purification

13.30–14.00 PD Prescription: The PDFs Choice
C Schmitt, Heidelberg, Germany
From composition to biocompatibility of the peritoneal dialysis fluids. Discuss the clinical place for the new PDFs

14.00–14.30 Assessment of the Peritoneal Membrane: Is the PET Enough?
B Warady, Kansas City, USA
How to test peritoneal membrane permeability; when and how to prescribe a PET; impact on prescription and outcome (hyperpermeability, hypopermeability: risks)  

14.30–15.00 Tea/Coffee    

15.00–15.30 Peritonitis: How to Manage IT?
F Schaefer, Heidelberg, Germany
How to define a peritonitis; what to do in terms of first choice for antibiotic treatment;  how to prescribe peritoneal dialysis over a peritonitis episode, how to prevent

15.30–16.00 The Peritoneal Catheter
J Terzic, and F Becmeur, Strasbourg, France
The catheter choice, the catheter placement, the catheter follow up, from babies to adolescents, a need for adequate management.

Pre-Conference Educational Course II

Cost: €50 - (Places must be pre-booked)

Chairs: N Lameire, Gent, Belgium;  B Faller, Colmar, France  

13.00–13.20 Peritoneal Physiology and Anatomy
N Lameire, Gent, Belgium
Overview of the anatomy of the peritoneal membrane, basic understanding of small solute transport and sodium sieving, 3 pore theory  

13.20–13.40 Peritoneal Cell Populations and their Relevance to Clinical PD
G Roberts,  Cardiff, UK
Overview of the resident cell populations in the peritoneal cavity and the peritoneal membrane, and how their function changes with PD duration and during infection.

13.40–14.00 Treatment Strategies for PD Related Peritonitis
R Krediet, Amsterdam, The Netherlands
Risk factors for peritonitis, the prevention of peritonitis, the need for epidemiologic studies, key issues when developing an empirical antibiotic therapy strategy.

14.00–14.20 Volume Management in PD
S Davies, Stoke on Trent, UK
Volume status in PD, importance of residual renal function, evaluation methods of volume status, how to achieve euvolemia.

14.20–14.50 Tea/Coffee

14.50–15.10 Optimal Clearance in PD
W Van Biesen, Gent, Belgium
Importance of small solute clearance, improving small solute clearance, avoiding high volume regimens, dwell time, dwell volumes, breakpoint analysis.

15.10–15.30 Enlarging the PD Population
J D Williams, Cardiff, UK
Strategies to enhance the numbers of incident patients starting on PD and strategies to improve technique success

15.30–15.50 Opportunities and Pitfalls of Assisted Care
C Verger, Pontoise, France
Different strategies to implement assisted care and different levels of assisted care

15.50-16.00 Discussion